MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202621066687 A) filed by Satya Ranjan Dalai; and Vijendra Kumar on May 27, 2026, for Development And Qbd Optimization Of Extended-Release Matrix Tablet Of Telmisartan Using Hpmc And Ethyl Cellulose.
Inventors include Satya Ranjan Dalai; and Vijendra Kumar.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: ABSTRACT TITLE: DEVELOPMENT AND QBD OPTIMIZATION OF EXTENDED-RELEASE MATRIX TABLET OF TELMISARTAN USING HPMC AND ETHYL CELLULOSE The present invention discloses an extended-release matrix tablet of Telmisartan (40 milligrams) employing hydroxypropyl methylcellulose (HPMC K4M) and ethyl cellulose as ra...